AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2005
Nov 16, 2005
35134_dirs_2005-11-16_54b1cb59-ae48-445c-b08d-41bed18d6cae.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2005-11-01
Reporting Person: JENSEN GERALD L (Director, President/CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-11-01 | Croff Enterprises Common Stock | P | 500 | $1.59 | Acquired | 248488 | Direct |
| 2005-11-14 | Croff Enterprises, Inc. Common Stock | P | 500 | $1.59 | Acquired | 248988 | Direct |
| 2005-11-15 | Croff Enterprises, Inc Common Stock | P | 1000 | $1.575 | Acquired | 249988 | Direct |
Footnotes
F1: This includes 132,130 shares of common held by Jensen Development Company which is wholly owned by Gerald L. Jensen.
F2: This includes 132,130 shares of common held by Jensen Development Company which is wholly owned by Gerald L. Jensen.
F3: This includes 132,130 shares of common held by Jensen Development Company which is wholly owned by Gerald L. Jensen.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 16